Value Assessment And Decision Making In The Face Of Uncertainty

There's been increasing interest in using Health Technology Assessment to guide coverage decisions and health policies. Recently, the COVID-19 experience has provided important lessons for value assessment of new interventions and its communication to stakeholders.

LEARN MORE

Value Assessment And Decision Making In The Face Of Uncertainty2022-01-31T10:21:20-05:00

Self-Reported Health Care Resource Utilization in Clinical Trials

Real-world data are important sources within health care resource utilization (HCRU) research, but these databases often are repurposed for this use rather than custom designed. Some researchers are beginning to collect HCRU data within the context of clinical trials, with the intention to address research questions of interest, rather than relying solely on data salvaged from insurance claims or electronic health records. 

LEARN MORE

Self-Reported Health Care Resource Utilization in Clinical Trials2022-01-18T12:57:42-05:00

Precision’s Stakeholder Insights

Using a multi-disciplinary, mixed methods approach to evidence generation, PRECISIONheor has an established track record of quantifying the value of treatment and communicating insights capturing the perspectives of key stakeholders.

LEARN MORE

Precision’s Stakeholder Insights2022-02-04T12:26:23-05:00

PRECISIONheor Executive Summary: NICE-UK Strategy 2021-2026

Recently, the National Institute for Health and Care Excellence (NICE) published a detailed strategy plan, outlining its vision during the next five years. Included in this report are new guidelines for technology evaluation, evidence standards, guidance adoption, and real-world data and research, which are applicable to all stakeholders, including the life science industry, regulators, healthcare providers, patients, and the public.

LEARN MORE

PRECISIONheor Executive Summary: NICE-UK Strategy 2021-20262021-11-11T11:01:03-05:00